pharmacie et médicaments – Conséquences de l'abaissement du plafond des remises sur les génériques

This written question asks about the impact of lowering the rebate ceiling for generic medicines. It seeks clarification on the consequences for the pharmaceutical sector and public health. The question affects pharmaceutical companies, healthcare providers, and patients who rely on generic medications. It could influence pricing strategies and access to affordable medicines.